Suppr超能文献

土耳其医生对哮喘降级治疗的态度:全国性视角

Physicians' attitudes towards step-down asthma treatment in Turkey: a nationwide perspective.

作者信息

Erbay Müge, Ayçiçek Olcay, Çebi Öztürk Deha

机构信息

Section of Immunology and Allergy Diseases, Department of Chest Diseases, Medical Faculty, Karadeniz Technical University, Trabzon, Turkey.

Department of Chest Diseases, Medical Faculty, Karadeniz Technical University, Trabzon, Turkey.

出版信息

Libyan J Med. 2025 Dec;20(1):2500192. doi: 10.1080/19932820.2025.2500192. Epub 2025 May 4.

Abstract

The cornerstone of asthma management is the stepwise approach recommended by both national and international guidelines. In this study, we aim to investigate physicians' attitudes and approaches towards step-down treatment in asthma management in Turkey. In this cross-sectional study, questionnaire-based data were gathered from pulmonologists, immunology and allergy specialists and immunology and allergy fellows in November-December 2024. Of the 225 physicians, the median years of service in their speciality was 5 (min1-max51) years. Nearly 35% of survey participants rarely step down asthma medication (12.9% and 52.4% of participants always and frequently, respectively). The two most selected barriers were 'I am afraid the patient will get worse' (50.9%) and 'patients don't want to' (29.9%). Participants whose primary concern regarding step-down asthma treatment was fear of patient deterioration were found to use step-down approaches less frequently (66.7%,  < 0.001). Working in educational and research hospitals, the fear that the patient may worsen, and infrequent adherence to guideline updates were significantly associated with the rare implementation of step-down treatment in asthma management. Our study identified that the fear of potential disease worsening and infrequent adherence to updated guidelines were significantly associated with the limited implementation of step-down treatment in asthma management.

摘要

哮喘管理的基石是国家和国际指南推荐的逐步治疗方法。在本研究中,我们旨在调查土耳其医生对哮喘管理中降级治疗的态度和方法。在这项横断面研究中,2024年11月至12月期间,通过问卷调查收集了肺科医生、免疫和过敏专科医生以及免疫和过敏专科住院医师的数据。在225名医生中,其专业服务年限的中位数为5年(最小值1年 - 最大值51年)。近35%的调查参与者很少减少哮喘药物用量(分别有12.9%和52.4%的参与者总是和经常减少用药)。最常被提及的两个障碍是“我担心患者病情会恶化”(50.9%)和“患者不愿意”(29.9%)。那些在哮喘降级治疗中主要担忧是患者病情恶化的参与者被发现较少使用降级治疗方法(66.7%,<0.001)。在教育和研究医院工作、担心患者病情可能恶化以及不经常遵循指南更新与哮喘管理中降级治疗的罕见实施显著相关。我们的研究发现,对潜在疾病恶化的恐惧和不经常遵循更新后的指南与哮喘管理中降级治疗的有限实施显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7a/12054564/765df6b0fea2/ZLJM_A_2500192_F0001_B.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验